MARKET RADAR
SENSEX     NIFTY      Refresh
Moneycontrol.com India | Accounting Policy > Pharmaceuticals > Accounting Policy followed by Astec Lifesciences - BSE: 533138, NSE: ASTEC
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > ACCOUNTING POLICY - Astec Lifesciences
Astec Lifesciences
BSE: 533138|NSE: ASTEC|ISIN: INE563J01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 24, 15:05
18.70
-0.45 (-2.35%)
VOLUME 1,777
LIVE
NSE
May 24, 15:08
18.75
-0.15 (-0.79%)
VOLUME 3,914
« Mar 11
Accounting Policy Year : Mar '12
I.  Basis of preparation of financial statements
 
 These financial statements have been prepared on an accrual basis and
 under historical cost convention and in compliance, in all material
 aspects, with the applicable accounting principles in India, the
 applicable accounting standards notified under 211 (30 and the other
 relevant provisions of the Companies Act, 1956.
 
 The company generally fallows mercantile system of accounting and
 recognizes significant items of income and expenditure on accrual
 basis.
 
 II. Use of Estimates
 
 The preparation or financial statements in conformity with generally
 accepted accounting principles requires estimates and assumptions to be
 made that affect the reported amounts of assets and liabilities on the
 date of the financial the reported amounts of revenues and expenses
 during the reporting period. Differences between actual results and are
 recognised in the period in which the results are known/materialised.
 
 III. Fixed Assets and Capital Work in Progress
 
 a) Fixed assets as accounted at cost of acquisition or construction
 less depreciation. The company capitalised all direct and indirect
 costs relating to the acquisition and installation of fixed assets.
 Interest on borrowed funds, if any used to finance
 acquisition/construction of fixed assets are capitalised till date of
 commercial production.
 
 b) Capital work in progress comprises outstanding advances paid to
 acquire Fixed Assets and cost of Fixed Assets that are not yet
 intalled.
 
 IV. Depreciation and Amortisation
 
 a) Depreciation has been provided on straight-line method at the rates
 and in the manner specified in schedule XIV to the companies Act, 1956.
 Depreciation is provided on pro-rata to the period of use,
 
 b) Leasehold land is amortised over the period of lease.
 
 V. Sales
 
 Revenue from sale of products includes sale value of goods and excise
 duty collected thereon, but excludes sales tax.
 
 Sales turnover are staled at net of trade discount and rebates granted
 during the ordinary course of business.
 
 VI.  Inventories
 
 Inventories of Raw Materials, Packing Material, Stores and Spares are
 valued ''at cost''. Finished Goods and Work in Progress are stated ''at
 cost or net realisable value, whichever is lower. Cost comprises all
 cost of purchase, cost of conversion and other costs incurred in
 bringing the inventories to their present location and condition.
 
 VII. Investments
 
 Investments are classified into Current and Long-term Investments.
 Current Investments are stated at lower of cost and fair value.
 Long-term Investments are stated at cost.
 
 VIII. Impairment of Fixed Assets
 
 At each Balance Sheet date, the company reviews the carrying value of
 tangible and intangible assets for any possible impairment. An
 impairment loss is recognised when the carrying amount of an asset
 exceeds its recoverable amount. The recoverable amount is higher of the
 asset''s net selling price or estimated future cash flows, which are
 discounted to their present value based on appropriate discount rates.
 During the year no provision for Impairment of fixed assets has been
 made.
 
 IX. Excise Duty and Custom Duty
 
 Excise duty/Customs duty has been accounted on the basis of payments
 made in respect of goods Cleared, Cenvat credit on raw materials and
 capital goods has been accounted for, by reducing the purchase cost of
 raw materials and capital goods respectively,
 
 X. Segment Reporting
 
 In accordance with the requirement of Accounting Standard -17, Segment
 Reporting issued by the Institute of Chartered Accountants of India,
 the Company''s Business Segment is Manufacturing of Agro and Pharma
 Chemicals and hence it has no other reportable segment.
 
 Thus the segment wise revenue, Segment wise result, total carrying
 amount of Segment wise assets and Segment wise liability, total cost
 incurred to acquire Segment wise assets, total amount of charge for
 deprecation during the year, is as reflected in the Financial Statement
 as of and for the year ended March 31, 2012.
 
 XI. Foreign Currency Transaction
 
 Foreign currency transactions are recorded at the rates of exchange
 prevailing on the date of the transaction. Exchange differences, if
 any, arising out of transactions settled during the year are recognized
 in the profit & loss account.
 
 Monetary assets and liabilities denominated in foreign currencies as at
 the balance sheet date are translated at the closing exchange rate on
 that date. The exchange differences if any, are recognised in the
 profit and loss account and related assets and liabilities are
 accordingly restated in the balance sheet
 
 XII. Retirement Benefits
 
 Provision for Gratuity & Leave encashment are made and provided on
 actuarial valuation basis.  Other retirement benefits are accounted as
 per company''s policy.
 
 XIII. In absence of information with the company, the nature of
 suppliers who are registered as micro.  Small or medium enterprises
 under the Micro, Small and Medium Enterprises Development Act 2006, as
 at 31st March 2012 have not been given.
Source : Dion Global Solutions Limited
Quick Links for asteclifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.